RadioMedix lands $40M Series A investment to advance cancer treatments


RadioMedix focuses on treatments for rare and aggressive cancers, specifically developing and advancing targeted alpha therapy and radiopharmaceuticals.

Previous Ampco-Pittsburgh subsidiary can borrow up to $20M
Next Encompass Health to add new hospital in Southeast